View in EDS

Ursodeoxycholic Acid Attenuates B Cell Susceptibility to SARS-CoV-2 Spike Protein by Interfering Its Binding to ACE2.

Saved in:
Bibliographic Details
Title: Ursodeoxycholic Acid Attenuates B Cell Susceptibility to SARS-CoV-2 Spike Protein by Interfering Its Binding to ACE2.
Authors: Park SJ; Department of Integrative Bioscience and Biotechnology, Sejong University, Seoul 05006, Republic of Korea., Moon EY; Department of Integrative Bioscience and Biotechnology, Sejong University, Seoul 05006, Republic of Korea.
Source: Biomolecules & therapeutics [Biomol Ther (Seoul)] 2025 Nov 01; Vol. 33 (6), pp. 1064-1072. Date of Electronic Publication: 2025 Oct 17.
Publication Type: Journal Article
Journal Info: Publisher: Korean Society of Applied Pharmacology Country of Publication: Korea (South) NLM ID: 101472832 Publication Model: Print-Electronic Cited Medium: Print ISSN: 1976-9148 (Print) Linking ISSN: 19769148 NLM ISO Abbreviation: Biomol Ther (Seoul) Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41102022
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Ursodeoxycholic Acid Attenuates B Cell Susceptibility to SARS-CoV-2 Spike Protein by Interfering Its Binding to ACE2.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Park+SJ%22">Park SJ</searchLink>; Department of Integrative Bioscience and Biotechnology, Sejong University, Seoul 05006, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Moon+EY%22">Moon EY</searchLink>; Department of Integrative Bioscience and Biotechnology, Sejong University, Seoul 05006, Republic of Korea.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101472832%22">Biomolecules & therapeutics</searchLink> [Biomol Ther (Seoul)] 2025 Nov 01; Vol. 33 (6), pp. 1064-1072. <i>Date of Electronic Publication: </i>2025 Oct 17.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Korean+Society+of+Applied+Pharmacology%22">Korean Society of Applied Pharmacology </searchLink><i>Country of Publication: </i>Korea (South) <i>NLM ID: </i>101472832 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Print <i>ISSN: </i>1976-9148 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2219769148%22">19769148 </searchLink><i>NLM ISO Abbreviation: </i>Biomol Ther (Seoul) <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41102022
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.4062/biomolther.2025.149
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1064
    Titles:
      – TitleFull: Ursodeoxycholic Acid Attenuates B Cell Susceptibility to SARS-CoV-2 Spike Protein by Interfering Its Binding to ACE2.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Park SJ
      – PersonEntity:
          Name:
            NameFull: Moon EY
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 11
              Text: 2025 Nov 01
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-print
              Value: 1976-9148
          Numbering:
            – Type: volume
              Value: 33
            – Type: issue
              Value: 6
          Titles:
            – TitleFull: Biomolecules & therapeutics
              Type: main
ResultId 1